Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

GLP-1 weight loss medications like Ozempic and Wegovy have ... Semaglutide, the active ingredient in Ozempic, is being developed in pill form by Novo Nordisk and has shown promising results ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

And while it’s still widely used for its intended purpose, helping diabetes patients to regulate blood sugar, Ozempic and its ...

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk (NVO) and Eli Lilly (LLY) by introducing GLP-1 pills.

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound ... medications say coverage has a ...